153
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Saxagliptin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Regulating the Nrf-2/HO-1 and NF-κB Pathways

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qingning Duan, Yin Jia, Yan Qin, Yingji Jin, Haozhong Hu & Jiebin Chen. (2020) Narciclasine attenuates LPS-induced acute lung injury in neonatal rats through suppressing inflammation and oxidative stress. Bioengineered 11:1, pages 801-810.
Read now

Articles from other publishers (6)

Shujing Li, Bin Jiang, Haiyang Yu & Dongqing Song. (2021) Regulation of PINX1 expression ameliorates lipopolysaccharide-induced lung injury and alleviates cell senescence during the convalescent phase through affecting the telomerase activity. Aging 13:7, pages 10175-10186.
Crossref
Jia Zhou, Zhengliang Peng & Jian Wang. (2021) Trelagliptin Alleviates Lipopolysaccharide (LPS)-Induced Inflammation and Oxidative Stress in Acute Lung Injury Mice. Inflammation.
Crossref
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, Ryoko Motonaga & Makito Tanabe. (2021) Renoprotective Effects of DPP-4 Inhibitors. Antioxidants 10:2, pages 246.
Crossref
Flavio A. Cadegiani. (2020) Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocrine Disorders 20:1.
Crossref
Quan Hu, Qin Wang, Chuangang Han & Yan Yang. (2020) Sufentanil attenuates inflammation and oxidative stress in sepsis-induced acute lung injury by downregulating KNG1 expression. Molecular Medicine Reports.
Crossref
Yinshan WuWeiliang JiangZhuhua LuWei SuNan LiuFeng Guo. (2020) miR-138-5p targets sirtuin1 to regulate acute lung injury by regulation of the NF-κB signaling pathway. Canadian Journal of Physiology and Pharmacology 98:8, pages 522-530.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.